Intellia Therapeutics Inc (NASDAQ:NTLA)
| 29.00 Delayed Data As of 3:59pm ET |  -0.78 / -2.62%Today’s Change | 22.67 Today|||52-Week Range 47.48 | -16.88% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Leonard John M President & Chief Executive Officer |  Sale | 1/04/2023 | 6,673 | $37.21 | $248.3K | -25.84% |
Clark Eliana Chief Technology Officer & Executive VP | Sale | 6/20/2023 | 5,000 | $45.00 | $225.0K | -33.47% |
Lebwohl David Chief Medical Officer & EVP | Sale | 1/04/2023 | 2,574 | $37.21 | $95.8K | -25.84% |
Sepp Lorenzino Laura Chief Science Officer & EVP | Sale | 1/04/2023 | 2,508 | $37.21 | $93.3K | -25.84% |
Goddard Glenn /archemix/ Chief Financial Officer & Executive Vice President | Sale | 1/04/2023 | 2,427 | $37.21 | $90.3K | -25.84% |
Bhanji Muna Director | Sale | 7/06/2023 | 1,867 | $39.30 | $73.4K | -25.82% |
Hicks Derek /intellia/ EVP & Chief Business Officer | Sale | 1/04/2023 | 1,812 | $37.21 | $67.4K | -25.84% |
Clark Eliana Chief Technology Officer & Executive VP | Sale | 1/04/2023 | 1,692 | $37.21 | $63.0K | -25.84% |
Sepp Lorenzino Laura Chief Science Officer & EVP | Sale | 1/05/2023 | 1,641 | $38.22 | $62.7K | -25.19% |
Clark Eliana Chief Technology Officer & Executive VP |  Buy | 6/20/2023 | 5,000 | $12.27 | $61.4K | -33.47% |
Page of 4